Syngene International P/E Ratio
Syngene International (SYNGENE) P/E ratio is 58.75 (High), EPS (TTM) ₹7.87, current price ₹460.40 on NSE vs historical average P/E of 50.72 (75.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see SYNGENE stock price BSE.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SYNGENE P/E Ratio — Valuation Signal & Historical Context
Syngene International P/E 58.75 vs historical average 50.72, range 19.89–100.37 — signal: Overvalued. Browse SYNGENE annual financials for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PE of 58.75, suggesting caution for new investments
- Trading at premium to sector average PE of 49.0
Syngene International P/E Ratio Historical Trend
SYNGENE annual price-to-earnings ratio — 8 years, EPS and year-end price. Current P/E 58.75 vs historical average 50.72. Analyse SYNGENE promoter holding to track promoter, FII and institutional holdings.
SYNGENE Historical P/E Ratio — EPS, Year-End Price & Valuation
Syngene International annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 100.37 | 8.76 | ₹879.25 | NSE | High |
| 2024 | 56.78 | 12.5 | ₹709.75 | NSE | High |
| 2023 | 46.87 | 12.37 | ₹579.75 | NSE | High |
| 2022 | 56.41 | 10.85 | ₹612.00 | NSE | High |
| 2021 | 62.24 | 10.16 | ₹632.35 | NSE | High |
| 2020 | 35.07 | 9.19 | ₹322.30 | NSE | High |
| 2019 | 28.15 | 9.9 | ₹278.70 | NSE | High |
| 2018 | 19.89 | 13.77 | ₹273.90 | NSE | Moderate |
SYNGENE vs Healthcare Peers — P/E Ratio Comparison
Syngene International P/E 58.75 vs Healthcare average 49.0, median 28.77 — range 0.97–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |